BACKGROUND AND AIM: The use of endoluminal flow diversion in bifurcation aneurysms has been questioned due to the potential for complications and lower occlusion rates. In this study we assessed outcomes of endovascular treatment of intracranial sidewall and bifurcation aneurysms with flow diverters. METHODS: In July 2020, a literature search for all studies utilizing endoluminal flow diverter treatment for sidewall or bifurcation aneurysms was performed. Data were collected from studies that met our inclusion/exclusion criteria by two independent reviewers and confirmed by a third reviewer. Using random-effects meta-analysis the target outcomes including overall complications (hematoma, ischemic events, minor ischemic stroke, aneurysm rupture, side vessel occlusion, stenosis, thrombosis, transient ischemic stroke, and other complications), perioperative complications, and follow-up (long-term) aneurysm occlusion were intestigated. RESULTS: Overall, we included 35 studies with 1084 patients with 1208 aneurysms. Of these aneurysms, 654 (54.14%) and 554 (45.86%) were classified as sidewall and bifurcation aneurysm, respectively, based on aneurysm location. Sidewall aneurysms had a similar total complication rate (R) of 27.12% (95% CI, 16.56%-41.09%), compared with bifurcation aneurysms (R, 20.40%, 95% CI, 13.24%-30.08%) (p = 0.3527). Follow-up angiographic outcome showed comparable complete occlusion rates for sidewall aneurysms (R 69.49%; 95%CI, 62.41%-75.75%) and bifurcation aneurysms (R 73.99%; 95% CI, 65.05%-81.31%; p = 0.4328). CONCLUSIONS: This meta-analysis of sidewall and bifurcation aneurysms treated with endoluminal flow diverters demonstrated no significant differences in complications or occlusion rates. These data provide new information that can be used as a benchmark for comparison with emerging devices for the treatment of bifurcation aneurysms.
BACKGROUND AND AIM: The use of endoluminal flow diversion in bifurcation aneurysms has been questioned due to the potential for complications and lower occlusion rates. In this study we assessed outcomes of endovascular treatment of intracranial sidewall and bifurcation aneurysms with flow diverters. METHODS: In July 2020, a literature search for all studies utilizing endoluminal flow diverter treatment for sidewall or bifurcation aneurysms was performed. Data were collected from studies that met our inclusion/exclusion criteria by two independent reviewers and confirmed by a third reviewer. Using random-effects meta-analysis the target outcomes including overall complications (hematoma, ischemic events, minor ischemic stroke, aneurysm rupture, side vessel occlusion, stenosis, thrombosis, transient ischemic stroke, and other complications), perioperative complications, and follow-up (long-term) aneurysm occlusion were intestigated. RESULTS: Overall, we included 35 studies with 1084 patients with 1208 aneurysms. Of these aneurysms, 654 (54.14%) and 554 (45.86%) were classified as sidewall and bifurcation aneurysm, respectively, based on aneurysm location. Sidewall aneurysms had a similar total complication rate (R) of 27.12% (95% CI, 16.56%-41.09%), compared with bifurcation aneurysms (R, 20.40%, 95% CI, 13.24%-30.08%) (p = 0.3527). Follow-up angiographic outcome showed comparable complete occlusion rates for sidewall aneurysms (R 69.49%; 95%CI, 62.41%-75.75%) and bifurcation aneurysms (R 73.99%; 95% CI, 65.05%-81.31%; p = 0.4328). CONCLUSIONS: This meta-analysis of sidewall and bifurcation aneurysms treated with endoluminal flow diverters demonstrated no significant differences in complications or occlusion rates. These data provide new information that can be used as a benchmark for comparison with emerging devices for the treatment of bifurcation aneurysms.
Authors: Christopher T Primiani; Zeguang Ren; Peter Kan; Ricardo Hanel; Vitor Mendes Pereira; Wai Man Lui; Nitin Goyal; Lucas Elijovich; Adam S Arthur; David M Hasan; Santiago Ortega-Gutierrez; Edgar A Samaniego; Ajit S Puri; Anna L Kuhn; Kirill Orlov; Dmitry Kislitsin; Anton Gorbatykh; Muhammad Waqas; Elad I Levy; Adnan H Siddiqui; Maxim Mokin Journal: J Neurointerv Surg Date: 2019-01-23 Impact factor: 5.836
Authors: A H Y Chiu; A K Cheung; J D Wenderoth; L De Villiers; H Rice; C C Phatouros; T P Singh; T J Phillips; W McAuliffe Journal: AJNR Am J Neuroradiol Date: 2015-05-21 Impact factor: 3.825
Authors: O Tanweer; E Raz; A Brunswick; D Zumofen; M Shapiro; H A Riina; M Fouladvand; T Becske; P K Nelson Journal: AJNR Am J Neuroradiol Date: 2014-08-21 Impact factor: 3.825
Authors: Krishnan Ravindran; Alejandro Enriquez-Marulanda; Peter T M Kan; Leonardo Renieri; Nicola Limbucci; Salvatore Mangiafico; Mohamed M Salem; Abdulrahman Y Alturki; Justin M Moore; Christopher S Ogilvy; Ajith J Thomas Journal: World Neurosurg Date: 2018-07-17 Impact factor: 2.104
Authors: Anil K Roy; Brian M Howard; Diogo C Haussen; Joshua W Osbun; Sameer H Halani; Susana L Skukalek; Frank Tong; Raul G Nogueira; Jacques E Dion; Charles M Cawley; Jonathan A Grossberg Journal: Neurosurgery Date: 2018-05-01 Impact factor: 4.654
Authors: L Pierot; J Moret; F Turjman; D Herbreteau; H Raoult; X Barreau; S Velasco; H Desal; A-C Januel; P Courtheoux; J-Y Gauvrit; C Cognard; S Soize; A Molyneux; L Spelle Journal: AJNR Am J Neuroradiol Date: 2015-02-05 Impact factor: 3.825
Authors: Maxim Mokin; Angel Chinea; Christopher T Primiani; Zeguang Ren; Peter Kan; Visish M Srinivasan; Ricardo Hanel; Pedro Aguilar-Salinas; Aquilla S Turk; Raymond D Turner; M Imran Chaudry; Andrew J Ringer; Babu G Welch; Vitor Mendes Pereira; Leonardo Renieri; Mariangela Piano; Lucas Elijovich; Adam S Arthur; Ahmed Cheema; Demetrius Klee Lopes; Ahmed Saied; Blaise W Baxter; Harris Hawk; Ajit S Puri; Ajay K Wakhloo; Hussain Shallwani; Elad I Levy; Adnan H Siddiqui; Guilherme Dabus; Italo Linfante Journal: J Neurointerv Surg Date: 2018-02-24 Impact factor: 5.836
Authors: Marta Aguilar Pérez; Hans Henkes; Wiebke Kurre; Carlos Bleise; Pedro Nicolás Lylyk; Javier Lundquist; Francis Turjman; Hanan Alhazmi; Christian Loehr; Stephan Felber; Hannes Deutschmann; Stephan Lowens; Luigi Delehaye; Markus Möhlenbruch; Jörg Hattingen; Pedro Lylyk Journal: J Clin Med Date: 2022-02-08 Impact factor: 4.241